scholarly journals mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer

2020 ◽  
Vol 21 (22) ◽  
pp. 8570
Author(s):  
Sonja Ludwig ◽  
Priyanka Sharma ◽  
Petra Wise ◽  
Richard Sposto ◽  
Deborah Hollingshead ◽  
...  

Human papillomavirus (HPV)(+) and HPV(−) head and neck cancer (HNC) cells’ interactions with the host immune system are poorly understood. Recently, we identified molecular and functional differences in exosomes produced by HPV(+) vs. HPV(−) cells, suggesting that genetic cargos of exosomes might identify novel biomarkers in HPV-related HNCs. Exosomes were isolated by size exclusion chromatography from supernatants of three HPV(+) and two HPV(−) HNC cell lines. Paired cell lysates and exosomes were analyzed for messenger RNA (mRNA) by qRT-PCR and microRNA (miR) contents by nanostring analysis. The mRNA profiles of HPV(+) vs. HPV(−) cells were distinct, with EGFR, TP53 and HSPA1A/B overexpressed in HPV(+) cells and IL6, FAS and DPP4 in HPV(−) cells. The mRNA profiles of HPV(+) or HPV(−) exosomes resembled the cargo of their parent cells. miR expression profiles in cell lysates identified 8 miRs expressed in HPV(−) cells vs. 14 miRs in HPV(+) cells. miR-205-5p was exclusively expressed in HPV(+) exosomes, and miR-1972 was only detected in HPV(−) exosomes. We showed that HPV(+) and HPV(−) exosomes recapitulated the mRNA expression profiles of their parent cells. Expression of miRs was dependent on the HPV status, and miR-205-5p in HPV(+) and miR-1972 in HPV(−) exosomes emerge as potential discriminating HPV-associated biomarkers.

2014 ◽  
Vol 111 ◽  
pp. S5-S6
Author(s):  
E. Tran ◽  
S.H. Huang ◽  
J. Waldron ◽  
X. Shen ◽  
W. Xu ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Marta Bogowicz ◽  
Arthur Jochems ◽  
Timo M. Deist ◽  
Stephanie Tanadini-Lang ◽  
Shao Hui Huang ◽  
...  

2020 ◽  
Vol 21 (9) ◽  
pp. 3388 ◽  
Author(s):  
Panagiota Economopoulou ◽  
Ioannis Kotsantis ◽  
Amanda Psyrri

The oropharynx has become the leading primary site for Human Papilloma Virus (HPV)-associated head and neck cancer. HPV positive oropharyngeal squamous cell carcinoma (HPV+ OSCC) has emerged as an epidemic not easily recognized by many physicians, resulting in delays in diagnosis and management. HPV+ OSCC traditionally refers to younger, healthier patients with high economic status and high-risk sexual behavior and is related to improved prognosis. De-intensification strategies are being evaluated in ongoing clinical trials and if validated, might help spare severe morbidity associated with current cisplatin-based chemoradiotherapy, which is the standard of care for all patients with locally advanced head and neck cancer. On the other hand, whether HPV status represents an important prognostic factor for non-oropharyngeal sites remains to be elucidated.


2019 ◽  
Vol 96 (3) ◽  
pp. 652-657 ◽  
Author(s):  
David Kessel ◽  
Won Jin Cho ◽  
Joseph Rakowski ◽  
Harold E. Kim ◽  
Hyeong‐Reh C. Kim

2007 ◽  
Vol 213 (3) ◽  
pp. 283-293 ◽  
Author(s):  
NF Schlecht ◽  
RD Burk ◽  
L Adrien ◽  
A Dunne ◽  
N Kawachi ◽  
...  

2007 ◽  
Vol 358 (1) ◽  
pp. 12-17 ◽  
Author(s):  
Nham Tran ◽  
Tessa McLean ◽  
Xiaoying Zhang ◽  
Chuan Jia Zhao ◽  
John Michael Thomson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document